Olanzapine plasma concentrations and clinical response: acute phase results of the north american olanzapine trial / Paul J. Perry en Journal of Clinical Psychopharmacology, Año 2001 - Vol. 21 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 1 (Febrero) . - pp. 14-20 Título : Olanzapine plasma concentrations and clinical response: acute phase results of the north american olanzapine trial Tipo de documento: texto impreso Autores: Paul J. Perry, Autor ; Brian C. Lund, Autor ; Todd Sanger, Autor Fecha de publicación: 2023 Artículo en la página: pp. 14-20 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Benzodiazepinas, Pirenzepina, Esquizofrenia. Resumen: Olanzapine is an atypical antipsychotic that is effective in the treatment of schizophrenia. Olanzapine plasma concentrations ≥ 9.3 ng/mL (24 hours postdose) have been identified as a predictor of clinical response in acutely ill patients with schizophrenia. The authors report a receiver operating characteristic (ROC) curve analysis of 12-hour olanzapine concentrations and treatment response from the North American Double-Blind Olanzapine Trial. Link: ./index.php?lvl=notice_display&id=31132 [artículo] Olanzapine plasma concentrations and clinical response: acute phase results of the north american olanzapine trial [texto impreso] / Paul J. Perry, Autor ; Brian C. Lund, Autor ; Todd Sanger, Autor . - 2023 . - pp. 14-20. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 1 (Febrero) . - pp. 14-20 Palabras clave: Antipsicóticos, Benzodiazepinas, Pirenzepina, Esquizofrenia. Resumen: Olanzapine is an atypical antipsychotic that is effective in the treatment of schizophrenia. Olanzapine plasma concentrations ≥ 9.3 ng/mL (24 hours postdose) have been identified as a predictor of clinical response in acutely ill patients with schizophrenia. The authors report a receiver operating characteristic (ROC) curve analysis of 12-hour olanzapine concentrations and treatment response from the North American Double-Blind Olanzapine Trial. Link: ./index.php?lvl=notice_display&id=31132

---

1 (1 - 1 / 1)